Cochlear Ltd
ASX:COH
Intrinsic Value
Cochlear Ltd. engages in the provision of implantable hearing solutions. [ Read More ]
The intrinsic value of one COH stock under the Base Case scenario is 198.3 AUD. Compared to the current market price of 319.99 AUD, Cochlear Ltd is Overvalued by 38%.
Valuation Backtest
Cochlear Ltd
Run backtest to discover the historical profit from buying and selling COH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Cochlear Ltd
Current Assets | 1.3B |
Cash & Short-Term Investments | 485.2m |
Receivables | 453.8m |
Other Current Assets | 388.4m |
Non-Current Assets | 1.2B |
Long-Term Investments | 155.2m |
PP&E | 455.9m |
Intangibles | 458.7m |
Other Non-Current Assets | 133.3m |
Current Liabilities | 517.4m |
Accounts Payable | 247.1m |
Accrued Liabilities | 106.5m |
Other Current Liabilities | 163.8m |
Non-Current Liabilities | 231.3m |
Long-Term Debt | 166.9m |
Other Non-Current Liabilities | 64.4m |
Earnings Waterfall
Cochlear Ltd
Revenue
|
2.1B
AUD
|
Cost of Revenue
|
-527.5m
AUD
|
Gross Profit
|
1.6B
AUD
|
Operating Expenses
|
-1.1B
AUD
|
Operating Income
|
491.1m
AUD
|
Other Expenses
|
-140.7m
AUD
|
Net Income
|
350.4m
AUD
|
Free Cash Flow Analysis
Cochlear Ltd
COH Profitability Score
Profitability Due Diligence
Cochlear Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Cochlear Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
COH Solvency Score
Solvency Due Diligence
Cochlear Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Cochlear Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
COH Price Targets Summary
Cochlear Ltd
According to Wall Street analysts, the average 1-year price target for COH is 290.52 AUD with a low forecast of 231.41 AUD and a high forecast of 383.25 AUD.
Shareholder Return
COH Price
Cochlear Ltd
Average Annual Return | 5.08% |
Standard Deviation of Annual Returns | 19.64% |
Max Drawdown | -37% |
Market Capitalization | 20.9B AUD |
Shares Outstanding | 65 494 100 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cochlear Ltd. engages in the provision of implantable hearing solutions. The company is headquartered in Sydney, New South Wales and currently employs 4,500 full-time employees. The firm designs and offers products and accessories for adults or children. The firm operates through three segments: Cochlear implants, Services and Acoustics. Its Cochlear implants segment offers cochlear implant systems, including Cochlear, Nucleus, Profile Plus implant and Slim Modiolar Electrode (CI632). The Company’s Services segment offers sound processor upgrades, accessories and other, including Cochlear Nucleus 7 Sound Processor and Cochlear Nucleus Kanso 2 Sound Processor. Its Acoustics segment offers bone conduction systems and sound processor upgrades, including Cochlear Baha 6 Max Sound Processor and Cochlear Osia 2 System. The firm operates in America; Europe, the Middle East and Africa (EMEA), and Asia Pacific.
Contact
IPO
Employees
Officers
The intrinsic value of one COH stock under the Base Case scenario is 198.3 AUD.
Compared to the current market price of 319.99 AUD, Cochlear Ltd is Overvalued by 38%.